BioXCell热销产品–RecombiMAb anti-mouse VEGFR-2

发表于由

BioXCell热销产品–RecombiMAb anti-mouse VEGFR-2

BioXCell热销产品–RecombiMAb anti-mouse VEGFR-2

 

产品描述：

DC101-CP132单克隆抗体是原始DC101单克隆的重组嵌合型抗体。可变结构域序列与原始DC101相同，但是恒定区序列已经从大鼠IgG1变为小鼠IgG2a。DC101-CP132单克隆抗体像原始大鼠IgG1抗体一样，不包含Fc突变。

 

DC101-CP132单克隆抗体能与小鼠VEGFR-2(血管内皮生长因子受体2)反应，VEGFR-2也称为CD309、KDR和Flk-1。VEGFR-2是酪氨酸蛋白激酶家族的成员。当结合到其配体血管内皮生长因子时发挥生理作用，血管内皮生长因子受体-2在血管发育和通透性中起关键作用。血管内皮生长因子受体-2在成人心脏、肺、肾、脑和骨骼肌的内皮细胞中高表达，在其他组织中低表达。DC101单克隆抗体已被证明在体内抑制VEGFR-2信号传导。

BioXCell热销产品--RecombiMAb anti-mouse VEGFR-2

产品详情：

产品名称

RecombiMAb anti-mouse VEGFR-2

产品货号

CP132

产品规格

1/5/25/50/100mg

反应种属

Mouse

克隆号

DC101-CP132

同种型

Mouse IgG2a(switched from rat IgG1)

免疫原

Mouse VEGFR-2-SEAPs soluble receptor

实验应用

in vivo blocking of VEGF/VEGFR-2 signaling*
in vitro blocking of VEGFR signaling*
Western blot*
*Reported for the original rat IgG1 DC101 antibody

产品形式

PBS, pH 7.0,Contains no stabilizers or preservatives

纯度

>95%, Determined by SDS-PAGE

聚合

<5%, Determined by SEC

无菌处理

0.2 µm filtration

纯化方式

Protein G

分子量

150 kDa

小鼠病原检测

Ectromelia/Mousepox Virus: Negative

Hantavirus: Negative

K Virus: Negative

Lactate Dehydrogenase-Elevating Virus: Negative

Lymphocytic Choriomeningitis virus: Negative

Mouse Adenovirus: Negative

Mouse Cytomegalovirus: Negative

Mouse Hepatitis Virus: Negative

Mouse Minute Virus: Negative

Mouse Norovirus: Negative

Mouse Parvovirus: Negative

Mouse Rotavirus: Negative

Mycoplasma Pulmonis: Negative

Pneumonia Virus of Mice: Negative

Polyoma Virus: Negative

Reovirus Screen: Negative

Sendai Virus: Negative

Theiler’s Murine Encephalomyelitis: Negative

保存条件

抗体原液保存在4°C，不能冷冻保存。

推荐同型对照

InVivoPlus mouse IgG2a isotype control, unknown specificity（货号BP0085）

推荐抗体稀释液

InVivoPure pH 7.0 Dilution Buffer（货号IP0070）

 

该产品自上市已被多篇SCI文献引用，品质有保证，以下是部分已发表的文献引用：

应用

文章

体内VEGF/VEGFR-2

信号阻断

(in vivo blocking of 

VEGF/VEGFR-2 signaling)

1. Ding, X., et al. (2015). ‘Distinct functions of epidermal and myeloid-derived 

VEGF-A in skin tumorigenesis mediated by HPV8′ Cancer Res 75(2): 330-343.


2. Lee, H. J., et al. (2015). ‘Inhibition of vascular endothelial growth factor A and 

hypoxia-inducible factor 1alpha maximizes the effects of radiation in sarcoma 

mouse models through destruction of tumor vasculature’ Int J Radiat Oncol Biol 

Phys 91(3): 621-630.


3. Arulanandam, R., et al. (2015). ‘VEGF-Mediated Induction of PRD1-BF1/Blimp1 

Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection’ Cancer Cell 

28(2): 210-224.


4. Kizhatil, K., et al. (2014). ‘Schlemm’s canal is a unique vessel with a combination 

of blood vascular and lymphatic phenotypes that forms by a novel developmental 

process’ PLoS Biol 12(7): e1001912.

体内VEGF/VEGFR-2信号阻断，

体外VEGFR信号阻断

(in vivo blocking of VEGF/VEGFR-2 

signaling, in vitro blocking of VEGFR 

signaling)

1.Larrayoz, M., et al. (2014). ‘Contrasting responses of non-small cell lung cancer to 

antiangiogenic therapies depend on histological subtype’ EMBO Mol Med 6(4): 539-550.  

 

 

更多产品详情请咨询 BioXCell 中国代理——上海金畔生物